Researchers from "Grigore T. Popa" University of Medicine and Pharmacy Detail New Studies and Findings in the Area of Relapsing-Remitting Multiple Sclerosis (The Faces of "Too Late"-A Surprisingly Progressive Cohort of "Stable".

Předmět:	NEUROLOGICAL disorders DEMYELINATION PROGNOSIS MULTIPLE sclerosis REPORTERS & reporting AUTOIMMUNE diseases
Zdroj:	Pain & Central Nervous System Week; 10/14/2024, p1015-1015, 1p
Abstrakt:	A new report from researchers at "Grigore T. Popa" University of Medicine and Pharmacy in Romania explores the progression of relapsing-remitting multiple sclerosis (RRMS) to secondary progressive MS (SPMS). The study evaluated clinical parameters and serum neurofilament light chain levels (sNfLs) as potential early warning signs of conversion to SPMS. The findings suggest that sNfL levels may be considered potential prognostic markers for MS progression, but further research is needed. The study also found that high-efficacy drugs did not provide additional protection against progression. The lack of early sensitive markers for progression risk may contribute to treatment delays and failures. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu